Are you Dr. Sovak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-2465Fax+1 732-212-0713
Summary
- Dr. Mika Sovak, MD is an oncologist in New Brunswick, New Jersey. She is currently licensed to practice medicine in California.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
Boston University School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2016
Clinical Trials
- Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Publications & Presentations
PubMed
- 1485 citationsCombined Vemurafenib and Cobimetinib in BRAF-Mutated MelanomaJames Larkin, Paolo A. Ascierto, Brigitte Dréno, Victoria Atkinson, Gabriella Liszkay
The New England Journal of Medicine. 2014-11-12 - 986 citationsOCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithe...Carol Aghajanian, Stephanie V. Blank, Barbara A. Goff, Patricia L. Judson, Michael Teneriello
Journal of Clinical Oncology. 2011-06-20 - 122 citationsTransient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation.Marcello Arsura, Ganesh R. Panta, Jennifer D. Bilyeu, Lakita G. Cavin, Mika A. Sovak
Oncogene. 2003-01-23
